Literature DB >> 3312024

Serologic response to Candida albicans and Aspergillus fumigatus in cystic fibrosis.

B Przyklenk1, A Bauernfeind, G Hörl, G Emminger.   

Abstract

In order to evaluate the role of fungi in patients with cystic fibrosis, we determined serum IgG antibodies against Candida albicans and Aspergillus fumigatus using an indirect ELISA in patients with or without fungi in the sputum and in sera of healthy individuals. For both C. albicans and A. fumigatus the antibody levels were significantly higher in the CF groups than in the control group, regardless of whether these fungi could be isolated during the observation time or not. In contrast to A. fumigatus, we found that in the majority of cases antibody levels increase significantly with the isolation of C. albicans from sputum. Therefore, we conclude that one has to pay more attention to C. albicans in CF patients. One must also particularly reevaluate long-term antibiotic treatment and look for means to prevent fungal recolonization and reinfection.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3312024     DOI: 10.1007/BF01644143

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  15 in total

1.  Long-term study of one hundred five patients with cystic fibrosis; studies made over a five- to fourteen-year period.

Authors:  H SHWACHMAN; L L KULCZYCKI
Journal:  AMA J Dis Child       Date:  1958-07

Review 2.  Cystic fibrosis.

Authors:  R E Wood; T F Boat; C F Doershuk
Journal:  Am Rev Respir Dis       Date:  1976-06

Review 3.  Pulmonary infection in cystic fibrosis.

Authors:  P A Friend
Journal:  J Infect       Date:  1986-07       Impact factor: 6.072

4.  Serum precipitins to Aspergillus fumigatus in cystic fibrosis.

Authors:  R H Schwartz; D E Johnstone; D S Holsclaw; R R Dooley
Journal:  Am J Dis Child       Date:  1970-11

5.  Atopy and bronchial reactivity in older patients with cystic fibrosis.

Authors:  M J Tobin; O Maguire; D Reen; E Tempany; M X Fitzgerald
Journal:  Thorax       Date:  1980-11       Impact factor: 9.139

6.  Suppression of host defences by Aspergillus fumigatus.

Authors:  M D Robertson; A Seaton; L J Milne; J A Raeburn
Journal:  Thorax       Date:  1987-01       Impact factor: 9.139

7.  Pulmonary candidiasis in cystic fibrosis.

Authors:  B M Jenner; L I Landau; P D Phelan
Journal:  Arch Dis Child       Date:  1979-07       Impact factor: 3.791

8.  Comparison of antibody measurements against Aspergillus fumigatus by means of double-diffusion and enzyme-linked immunosorbent assay (ELISA).

Authors:  H F Kauffman; F Beaumont; H Meurs; S van der Heide; K de Vries
Journal:  J Allergy Clin Immunol       Date:  1983-09       Impact factor: 10.793

9.  Prednisolone in the treatment of airflow obstruction in adults with cystic fibrosis.

Authors:  C F Pantin; R J Stead; M E Hodson; J C Batten
Journal:  Thorax       Date:  1986-01       Impact factor: 9.139

10.  Allergic bronchopulmonary aspergillosis complicating cystic fibrosis in childhood.

Authors:  M J Brueton; L P Ormerod; K J Shah; C M Anderson
Journal:  Arch Dis Child       Date:  1980-05       Impact factor: 3.791

View more
  12 in total

Review 1.  Alzheimer disease.

Authors:  David S Knopman; Helene Amieva; Ronald C Petersen; Gäel Chételat; David M Holtzman; Bradley T Hyman; Ralph A Nixon; David T Jones
Journal:  Nat Rev Dis Primers       Date:  2021-05-13       Impact factor: 52.329

2.  Treatment of infections in patients with cystic fibrosis.

Authors:  M I Marks
Journal:  Infection       Date:  1987       Impact factor: 3.553

3.  The Role of Oxytocin in Social Circuits and Social Behavior in Dementia.

Authors:  Olivier Piguet; Rebekah M Ahmed; Fiona Kumfor
Journal:  Methods Mol Biol       Date:  2022

Review 4.  Microbiology of airway disease in patients with cystic fibrosis.

Authors:  P H Gilligan
Journal:  Clin Microbiol Rev       Date:  1991-01       Impact factor: 26.132

5.  Sustained attention failures on a 3-min reaction time task is a sensitive marker of dementia.

Authors:  Aurélie L Manuel; David Foxe; Nathan Bradshaw; Nicholas J Cordato; John R Hodges; James R Burrell; Olivier Piguet
Journal:  J Neurol       Date:  2019-03-05       Impact factor: 4.849

Review 6.  An update on blood-based biomarkers for non-Alzheimer neurodegenerative disorders.

Authors:  Nicholas J Ashton; Abdul Hye; Anto P Rajkumar; Antoine Leuzy; Stuart Snowden; Marc Suárez-Calvet; Thomas K Karikari; Michael Schöll; Renaud La Joie; Gil D Rabinovici; Kina Höglund; Clive Ballard; Tibor Hortobágyi; Per Svenningsson; Kaj Blennow; Henrik Zetterberg; Dag Aarsland
Journal:  Nat Rev Neurol       Date:  2020-04-22       Impact factor: 42.937

Review 7.  Tau PET imaging in neurodegenerative tauopathies-still a challenge.

Authors:  Antoine Leuzy; Konstantinos Chiotis; Laetitia Lemoine; Per-Göran Gillberg; Ove Almkvist; Elena Rodriguez-Vieitez; Agneta Nordberg
Journal:  Mol Psychiatry       Date:  2019-01-11       Impact factor: 15.992

8.  Identifying a subtype of Alzheimer's disease characterised by predominant right focal cortical atrophy.

Authors:  Ko Woon Kim; Seongbeom Park; Hyunjin Jo; Soo Hyun Cho; Seung Joo Kim; Yeshin Kim; Hyemin Jang; Duk L Na; Sang Won Seo; Hee Jin Kim
Journal:  Sci Rep       Date:  2020-04-29       Impact factor: 4.379

9.  Infections in cystic fibrosis.

Authors:  Kathy A Marks-Austin; Stanley B Fiel; Preston W Campbell; Terrence L Stull
Journal:  Semin Pediatr Infect Dis       Date:  2006-05-31

10.  Concordance in detecting amyloid positivity between 18F-florbetaben and 18F-flutemetamol amyloid PET using quantitative and qualitative assessments.

Authors:  Soo Hyun Cho; Yeong Sim Choe; Young Ju Kim; Byungju Lee; Hee Jin Kim; Hyemin Jang; Jun Pyo Kim; Young Hee Jung; Soo-Jong Kim; Byeong C Kim; Gill Farrar; Duk L Na; Seung Hwan Moon; Sang Won Seo
Journal:  Sci Rep       Date:  2020-11-11       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.